Enlarged Prostate Drug Allows for Less Invasive Prostate Biopsies

Main Category: Prostate / Prostate Cancer
Article Date: 19 May 2005 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


A drug that is currently used to treat an enlarged prostate may improve the accuracy of prostate biopsies, a pilot study shows.

The drug, dutasteride, suppresses blood flow in benign tissue of the prostate, allowing radiologists to better target cancer tissue using Doppler ultrasound, said Elizabeth Ives, MD, a research fellow at Thomas Jefferson University Hospital in Philadelphia and lead author of the study. The study included 11 patients who took dutasteride before their Doppler ultrasound-guided prostate biopsy. Based on blood flow reduction, biopsy was performed on one patient after one week of taking the drug, eight patients after two weeks of taking the drug and two patients after three weeks of taking the drug. Up to four targeted biopsies as well as six standard biopsies were performed on each patient. Prostate cancer was detected in four of the patients using the targeted biopsy method; the standard method detected three of the four cancers, Dr. Ives said. "If we can reduce the benign blood flow, we're better able to see where the cancer tissue is located, and detect cancer if it is present," she said.

Currently about 10% of men who have a prostate biopsy need to have a repeat procedure done, said Dr. Ives. "If cancer is there and we find it on the first biopsy, these men can be diagnosed sooner and be spared from having to undergo a repeat biopsy," she said.

Dr. Ives' mentor for the research project is Ethan Halpern, MD, at Thomas Jefferson University. The study results will be presented at the American Roentgen Ray Society Annual Meeting on May 19 in New Orleans, LA.

The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the U.S. Radiologists from all over the world attend the ARRS Annual Meeting to take part in instructional courses, scientific paper presentations, symposiums, new issues forums and scientific and commercial exhibits related to the field of radiology. The ARRS is named after Wilhelm Röentgen, who discovered the x-ray in 1895.

Contact: Keri Sperry
keri@arrs.org
703-858-4306
American Roentgen Ray Society
http://www.arrs.org

View drug information on dutasteride.


Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Keri Sperry. "Enlarged Prostate Drug Allows for Less Invasive Prostate Biopsies." Medical News Today. MediLexicon, Intl., 19 May. 2005. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/24710.php>

APA
Keri Sperry. (2005, May 19). "Enlarged Prostate Drug Allows for Less Invasive Prostate Biopsies." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/24710.php.

Please note: If no author information is provided, the source is cited instead.


Prostate / Prostate Cancer

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »